유전자 편집 완벽 가이드.
메뉴
배우기 뉴스 아틀라스에 질문하기
둘러보기 기술들 질환 치료법들 임상시험 기업 과학자들 유전자 연구 기관
의학을 넘어서 농업 윤리 투자 세계 지도
배우기 & 도구 여기서 시작하세요 용어집 A–Z 기술 비교 타임라인 목록 & 순위 AI 에이전트 ★ 저장됨 API
소개 소개 방법론 데이터 출처 편집 방침 문의 면책 조항

🧭 안내 보기
유전학이 처음이신가요? 둘러보시는 동안 모든 용어를 쉬운 말로 설명해 드립니다. 도움말이 내장된 동일한 페이지입니다.

⚡ 전문가 견해
생물학은 이미 알고 계시죠. 내용만 — 깔끔하고 간결하게, 추가 설명 없이. 기본 보기입니다.

인터페이스 언어
라이트 모드

Research

Important Discoveries in Gene Editing

The papers that changed what was possible, each summarised and linked to the original.

이 목록이 만들어지는 방식

Eleven papers, from the first recognition of what CRISPR was for to the first patients treated with prime editing. Each entry explains what changed and links to the original publication.

#항목카테고리 상태
1 A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity The paper that turned CRISPR from a curiosity of bacterial immunity into a programmable… Foundational
2 Multiplex genome engineering using CRISPR/Cas systems One of the two January 2013 papers showing that CRISPR works inside human cells. Foundational
3 RNA-guided human genome engineering via Cas9 The companion January 2013 paper from George Church's laboratory, published the same day. Foundational
4 Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage The paper that introduced base editing — chemistry instead of cutting. Method
5 Search-and-replace genome editing without double-strand breaks or donor DNA The paper introducing prime editing — writing new sequence directly into the genome. Method
6 CRISPR provides acquired resistance against viruses in prokaryotes The experiment, performed at a yogurt company, that proved CRISPR is a bacterial immune… Foundational
7 CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia The first published clinical results showing CRISPR editing produced benefit in patients. Clinical
8 CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis The first report of CRISPR administered into a human bloodstream to edit a gene inside… Clinical
9 Patient-specific in vivo gene editing to treat a rare genetic disease The first gene-editing medicine designed and manufactured for a single patient. Clinical
10 Prime editing for p47phox-deficient chronic granulomatous disease The first published evidence that prime editing works in human patients. Clinical
11 Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements The insight that CRISPR spacers come from viruses — the origin of the whole field. Foundational
이 목록이 알려주지 않는 것A curated selection, not a systematic review. We summarise and link; we do not reproduce copyrighted articles.
Written by The CRISPR Atlas editorial team Last updated Aug 25, 2026